Mount Yale Investment Advisors, LLC Halozyme Therapeutics, Inc. Transaction History
Mount Yale Investment Advisors, LLC
- $1.2 Billion
- Q4 2024
A detailed history of Mount Yale Investment Advisors, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Mount Yale Investment Advisors, LLC holds 5,673 shares of HALO stock, worth $315,588. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,673
Previous 14,978
62.12%
Holding current value
$315,588
Previous $856,000
68.34%
% of portfolio
0.02%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding HALO
# of Institutions
538Shares Held
125MCall Options Held
294KPut Options Held
180K-
Black Rock Inc. New York, NY17.6MShares$980 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$717 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$369 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$226 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$190 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.75B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...